Genomic analysis of tumors: MERCURY™
MERCURY™ is a tumor molecular profiling analysis software and online biological interpretation tool designed for oncology. It enables clinicians and researchers to transform raw data from high-throughput sequencing (WES, WGS, panel, RNAseq) into actionable molecular reports, facilitating translational and clinical research.
MOLECULAR PROFILING OF TUMORS FOR TRANSLATIONAL & CLINICAL RESEARCH
The intuitive MERCURY™ interface enables users to quickly visualize an accurate and comprehensive molecular tumor profile for cancer patients after rapid analysis of their sequencing data (constitutional tumor DNA and tumor RNA).
MERCURY™ also provides users with access to numerous annotation databases, links to potential clinical trials and treatment options based on identified variants, as well as the ability to create and export a customizable report.
TRANSFORMING SEQUENCING DATA INTO KNOWLEDGE
MERCURY™ IS NOW CUSTOMIZABLE FOR LARGE AND SMALL GENE PANELS
MERCURY™ is now fully adaptable to your data analysis needs with the ability to handle oncology sequencing data ranging from broad sequencing (WES, RNA-Seq, WGS) to large gene panels and all the way to targeted gene panels. Whether you use a third-party panel available on the market or have developed your own, IntegraGen will work with you to customize the data analysis and reporting pipeline for the clinical sequencing you perform.
